High cumulative doxorubicin dose for advanced soft tissue sarcomaZhichao Tian, Xin Wang, Yang Yang et al.|BMC Cancer|2020Cited by 41
T Cells Expanded from PD-1+ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Cancer Research|2021Cited by 40
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective studyZhichao Tian, Weitao Yao, Shuping Dong et al.|BMC Cancer|2022Cited by 19
<p>Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study</p>Zhichao Tian, Jiaqiang Wang, Yonghao Yang et al.|Cancer Management and Research|2020Cited by 16
Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trialZhichao Tian, Weitao Yao, Shuping Dong et al.|Frontiers in Pharmacology|2022Cited by 10